Factors Determining Quality of Drug Information by Hospital Pharmacies—Results from Five-Year Annual Quality Assessment

Author:

Strobach Dorothea12,Chiriac Ute3ORCID,Klausner Sigrun4,Krebs Sabine5ORCID,Langebrake Claudia67ORCID,Querbach Christiane8,Schuhmacher Carolin9,Schulte Rickmer10,Wiegrebe Simon10ORCID,Amann Ute11

Affiliation:

1. Hospital Pharmacy, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany

2. Doctoral Program Clinical Pharmacy, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany

3. Department of Pharmacy, University Hospital of Heidelberg, Im Neuenheimer Feld 670, 69120 Heidelberg, Germany

4. Landesapotheke Salzburg, Muellner Hauptstr. 50, 5020 Salzburg, Austria

5. Pharmacy Department, Erlangen University Hospital, Palmsanlage 3, 91054 Erlangen, Germany

6. Hospital Pharmacy, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany

7. Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany

8. Hospital Pharmacy Department, Klinikum Rechts der Isar, Technische Universität Munich, Ismaninger Straße 22, 81675 Munich, Germany

9. Hospital Pharmacy, Schwarzwald-Baar Hospital Villingen-Schwenningen, Klinikstr. 11, 78050 Villingen-Schwenningen, Germany

10. Statistical Consulting Unit StaBLab, Department of Statistics, LMU Munich, Ludwigsstraße 33, 80539 Munich, Germany

11. Faculty of Medicine at LMU Munich, 80336 Munich, Germany

Abstract

Drug information (DI) provided by hospital pharmacies aims to promote rational and safe drug therapy. While quality assessment for this task is recommended, more knowledge on the factors determining the quality is needed. We aimed to evaluate the impacts of different factors on the quality of DI provided by hospital pharmacies to healthcare professionals. Retrospectively, answers on fictitious enquiries about annual DI tests for German hospital pharmacies over five years were evaluated for content-related and structural requirements. Multivariate analysis was performed for the impact of the enquiry complexity, DI organization (specialized DI center; pharmacist responsible per day; DI on top of other routine tasks), and quality measures (second look; experience of answering pharmacist in DI/on ward; use of documentation database). In 2017–2021, 45, 71, 79, 118, and 122 hospital pharmacies participated. The enquiry complexity had a statistically significant impact on the content-related quality, with poor results for a higher complexity (years 2018/2021, OR 0.25/0.04, p < 0.01). The DI centers achieved better results regarding content-related quality than for a pharmacist responsible per day (OR 0.76/p = 0.65) or DI on top of routine tasks (OR 0.35/p = 0.02). The DI centers scored better in structural quality. The second look showed an overall trend of a better content-related and structural quality. In conclusion, specialized DI centers and second looks are recommended as quality-improving measures. Training for answering complex enquiries should be intensified.

Funder

Stiftung Patient & Klinische Pharmazie, Munich, Germany

Publisher

MDPI AG

Reference38 articles.

1. WHO (2024, January 06). Policy Perspectives on Medicines (2002) Promoting Rational Use of Medicines: Core Components. Available online: https://iris.who.int/bitstream/handle/10665/67438/WHO_EDM_2002.3.pdf.

2. International Pharmaceutical Federation (FIP) (2024, January 06). Requirements for Drug Information Centre. Available online: http://www.cff.org.br/userfiles/file/cebrim/RequirementsforDrugInformationCentres%202005%20final.pdf.

3. ASHP guidelines on the pharmacist’s role in providing drug information;Ghaibi;Am. J. Health Syst. Pharm.,2015

4. (2024, January 06). Arzneimittelinformation aus der Krankenhausapotheke. Leitlinie der ADKA, Stand 15.09.2021. Available online: https://www.krankenhauspharmazie.de/heftarchiv/2021/11/arzneimittelinformation-aus-der-krankenhausapotheke-leitlinie-der-adka-zur-qualitaetssicherung-stand-der-letzten-aenderung-15-09-2021.html.

5. Drug information services today: Current role and future perspectives in rational drug therapy;Reppe;Clin. Ther.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3